Table 1.

Clinical, electrocardiographic, and angiographic variables of the patients.

	STEMI	HD	SCAD
Number of patients, n	20	20	20
Age, median (range)	65.5 (51–82)	62.5 (49–81)	63.5 (51–80)
Gender
Male, n (%)	15 (75)	15 (75)	15 (75)
Female, n (%)	5 (25)	5 (25)	5 (25)
Family history
n (%)	7 (35)	0 (0)	3 (15)
Hypertension
n (%)	11 (55)	0 (0)	17 (85)
Smoking
n (%)	10 (50)	0 (0)	3 (15)
Dyslipidemia
n (%)	9 (45)	0 (0)	11 (55)
Diabetes Mellitus
n (%)	5 (25)	0 (0)	7 (35)
Obesity
n (%)	2 (10)	0 (0)	3 (15)
ST elevation
Inferior- lateral, n (%)	3 (15)	no	no
Anterior, n (%)	9 (45)	no	no
Inferior, n (%)	7 (35)	no	no
Lateral, n (%)	1 (5)	no	no
Angiography
CX occlusion, n (%)	4 (20)	n/a	1 (5)
LAD occlusion, n (%)	9 (45)	n/a	10
RCA occlusion, n (%)	7 (35)	n/a	1
CX, LAD	0	n/a	2
CX, RCA	0	n/a	1
LAD, RCA	0	n/a	1
CX, LAD, RCA	0	n/a	4
Thrombosis
n (%)	20 (100)	n/a	no
CK-MB, mean ± SD	172.39 ± 95.30	normal	normal
Tn I, mean ± SD	48.44 ± 28.32	normal	normal
Aspirin
n (%)	6 (30)	0 (0)	20 (100)
P2Y12 Inhibitors
n (%)	0 (0)	0 (0)	0 (0)
Anticoagulants
n (%)	0 (0)	0 (0)	0 (0)

Family history of ischemic heart disease in a first-degree relative before 55 years in men and before 65 years in women; ST elevation: location of ST elevation; CX: circumflex coronary artery; LAD: left anterior descending coronary artery; RCA: right coronary artery; Thrombosis: presence of coronary thrombosis at angiography; CK-MB: CK-MB peak in ng/mL; Tn-I: Troponin I peak in ng/ml. Aspirin: patients on treatment with aspirin; P2Y12 Inhibitors: patients on treatment with P2Y12 inhibitors; Anticoagulants: patients on treatment with anticoagulants n: number of patients. N/A: not applicable.